Cardiogenomic Testing Alliance Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 873531345 ✦ Washington, DC ✦ Designated as a 501(c)(6)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Cardiogenomic Testing Alliance Inc?

Cardiogenomic Testing Alliance Inc is a nonprofit organization located at 1001 Pennsylvania Avenue NW, 1300N, Washington DC 20004. Its mission is to unite various entities, including genomics companies, laboratories, digital health companies, advocacy groups, and key leaders in cardiology. The alliance aims to promote the awareness and utilization of genomic testing in cardiology. By educating healthcare providers and other stakeholders, the Cardiogenomic Testing Alliance seeks to ensure adherence to existing guidelines from professional medical societies, inform medical management, and enhance cascade testing. Ultimately, the goal is to improve clinical outcomes in cardiology.


Official website here: www.cardiogenomictesting.com

Is Cardiogenomic Testing Alliance Inc legitimate?

Cardiogenomic Testing Alliance Inc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Cardiogenomic Testing Alliance Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.cardiogenomictesting.com

What is the mission statement of Cardiogenomic Testing Alliance Inc?

The Cardiogenomic Testing Alliance (CGTA) aims to promote the awareness and utilization of genetic testing in the field of cardiology. Their mission is to educate healthcare providers and other stakeholders about the value of such testing. The goal is to ensure adherence to existing guidelines from professional medical societies, inform medical management and cascade testing, and ultimately improve clinical outcomes. In simpler terms, the alliance aims to raise awareness and encourage the use of genetic testing in cardiology, providing education to healthcare providers to improve patient care.


Official website here: www.cardiogenomictesting.com

Who is the CEO of Cardiogenomic Testing Alliance Inc?

Tom Fagley is the Chair of Cardiogenomic Testing Alliance Inc.


Official website here: www.cardiogenomictesting.com

What is the revenue of Cardiogenomic Testing Alliance Inc?

Cardiogenomic Testing Alliance Inc's revenue in 2022 was $240,000.


Official website here: www.cardiogenomictesting.com

Who are the executives of Cardiogenomic Testing Alliance Inc and what are their salaries?


Here are 5 key members and their salaries:


Melissa Dempsey (Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Christin Coffeen (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Nora Sanzo (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Marily Rhudy (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tom Fagley (Assistant Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.cardiogenomictesting.com

Where can I find the form 990 for Cardiogenomic Testing Alliance Inc?

Cardiogenomic Testing Alliance Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.cardiogenomictesting.com

Learn more at the official website: www.cardiogenomictesting.com

Mission Statement of Cardiogenomic Testing Alliance Inc

Cardiogenomic Testing Alliance (CTA) is committed to raising awareness and promoting the utilization of genetic testing in the field of cardiology. The primary objective of this alliance is to educate healthcare providers and various stakeholders about the significance of genetic testing. By doing so, CTA aims to ensure compliance with existing guidelines from professional medical societies. This education plays a crucial role in informing medical management and cascade testing, ultimately aiming to enhance clinical outcomes. In simpler terms, Cardiogenomic Testing Alliance works to spread knowledge about the value of genetic testing in cardiology, encouraging healthcare providers to adhere to established guidelines and improve patient care.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Cardiogenomic Testing Alliance Inc significantly enhances the integration of genomic testing within cardiology, focusing on improving patient outcomes through education and awareness. By uniting various stakeholders—including genomics companies, laboratories, digital health firms, advocacy groups, and cardiology leaders—the Alliance fosters collaboration aimed at increasing the utilization of genomic testing practices.

One of the primary impacts of the Alliance is its commitment to educating healthcare providers about the clinical benefits of genomic testing. This education ensures adherence to established guidelines from professional medical societies, which is crucial for informed medical management and cascade testing. As a result, patients receive more precise and tailored medical care based on their genetic profiles, ultimately leading to better clinical outcomes.

Furthermore, the Alliance actively promotes awareness of genetic testing in cardiology, which can lead to timely interventions and improved patient prognoses. By lobbying for a more cohesive approach to genomic testing, Cardiogenomic Testing Alliance Inc plays a vital role in shaping the future of cardiovascular care, emphasizing the importance of leveraging genomic data for enhanced healthcare delivery.




This information is meant to be a general summary of Cardiogenomic Testing Alliance Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$240,000 (2022)
Expenses
$159,078 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Gross Receipts: $240,000

Assets and Liabilities:

  • Total Assets: $81,072
  • Total Liabilities: $150
  • Net Assets: $80,922

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2021

Principal Officer

Tom Fagley

Main Address

1001 PENNSYLVANIA AVE NW 1300N, WASHINGTON, DC, 20004

NTEE Category

Code: S41 - Community improvement

If you are a representative of Cardiogenomic Testing Alliance Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.